About Unnati Pharmaceuticals Private Limited
Data last updated:
Unnati Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 24 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2003PTC428884. Its GSTIN is 27AAACU6175D1ZC (Maharashtra). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹10.5 Lakh and a paid-up capital of ₹9.02 Lakh. It is led by directors Naishil Hetal Mehta and Hetal Bhupatrai Mehta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹154.64 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹46.98 Lakh (net margin 0.3%) and EBITDA of ₹1.25 Cr (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 14% over five years.
The company is associated with 1 brand: Unnati Pharmaceutical. As per MCA filings, the company has open charges of ₹12.88 Cr on record. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹9 Lakh; the latest was in January 2019. Its 3 peer companies in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Elysium Pharmaceuticals Ltd with revenue of ₹159.55 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unnatipharmaceuticals.com.
Company details
CIN history
Unnati Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231GJ2003PTC042538. The current CIN is U24231MH2003PTC428884, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH2003PTC428884 | Current |
| U24231GJ2003PTC042538 | Previous |
Contact details
Unnati Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is unnatipharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No 301/401 Sai Chambers Chs Ltd Road No 3, Near Santacruz Bus Depot, Mumbai, Maharashtra, India – 400055
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Unnati Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Unnati Pharmaceuticals operates one associated brand: Unnati Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a supplier of APIs, enzymes, nutraceuticals, pellets, excipients, and related products. | unnatipharmaceuticals.com |
Financials of Unnati Pharmaceuticals Private Limited
FY 2024 filings availableUnnati Pharmaceuticals Private Limited reported revenue of ₹154.64 Cr (down 3% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹154.64 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unnati Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unnati Pharmaceuticals Private Limited
Unnati Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naishil Hetal Mehta Also directs: Enkay Cosmetics LLP | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Hetal Bhupatrai Mehta | Director | 30 Jun 2010 | 16 Years 4 Months | Current |
Peer comparison
Unnati Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elysium Pharmaceuticals Ltd | ₹159.55 Cr (FY 2024) | -26.0% | Vadodara, Gujarat, India | |||
| Dynamic (CG) Equipments Private Limited | ₹158.82 Cr (FY 2016) | -27.0% | Bhilai, Chhattisgarh, India | |||
| Jenburkt Pharmaceuticals Ltd | ₹158.41 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Unnati Pharmaceuticals Private Limitedthis company | ₹154.64 Cr (FY 2023) | ₹46.98 Lakh | 0.3% | -3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Unnati Pharmaceuticals Private Limited, buy the company report.
Auditor
Unnati Pharmaceuticals Private Limited is audited by J.H. & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J.H. & CO. | FY 2023 | 115320W |
Shareholding
The shareholding of Unnati Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unnati Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2022 | 100558502 | Hdfc Bank Limited | ₹13.35 Lakh | Open | |
| 12 Mar 2018 | 100193433 | Hdfc Bank Limited | ₹5 Cr | Open | |
| 28 Feb 2008 | 10114657 | Hdfc Bank Limited | ₹7.75 Cr | Open |
To see the full charge records of Unnati Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Unnati Pharmaceuticals Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹9 Lakh; the latest was in January 2019.
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2009 | Funding round | ₹8 Lakh | Investors: an individual |
| Mar 2006 | Funding round | ₹1 Lakh | Investors: 4 individuals |
To see the full deal history of Unnati Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Unnati Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unnati Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unnati Pharmaceuticals has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACU6175D1ZC | Maharashtra | Active | 01 Jul 2017 |
| 27AAACU6175D2ZB | Maharashtra | Active | 24 Mar 2025 |
| 02AAACU6175D1ZO | Himachal Pradesh | Active | 01 Jul 2017 |
| 24AAACU6175D1ZI | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unnati Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unnati Pharmaceuticals Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Naishil Hetal Mehta ceased to be Additional Director on 30 Sep 2017.
1 earlier event is in the company report.
Frequently asked questions
Unnati Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 24 June 2003 (23+ years old) and is registered under CIN U24231MH2003PTC428884.
Unnati Pharmaceuticals has 2 current directors:
- Naishil Hetal Mehta - Director
- Hetal Bhupatrai Mehta - Director
The latest financial statements of Unnati Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Unnati Pharmaceuticals is 27AAACU6175D1ZC, registered in Maharashtra. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 27AAACU6175D2ZB (Maharashtra), 02AAACU6175D1ZO (Himachal Pradesh), 24AAACU6175D1ZI (Gujarat).
The CIN (Corporate Identification Number) of Unnati Pharmaceuticals is U24231MH2003PTC428884. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unnati Pharmaceuticals was incorporated on 24 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Unnati Pharmaceuticals has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹9 Lakh; the latest was in January 2019.
The peers of Unnati Pharmaceuticals by revenue are Elysium Pharmaceuticals Ltd, Dynamic (CG) Equipments Private Limited, Jenburkt Pharmaceuticals Ltd, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Naishil Hetal Mehta ceased to be Additional Director on 30 Sep 2017. Naishil Hetal Mehta was appointed as Director on 21 Dec 2016. Rahul Jitendra Parekh ceased to be Additional Director on 21 Dec 2016. Unnati Pharmaceuticals has 6 board changes on record in total.
Unnati Pharmaceuticals can be reached through the website unnatipharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Unnati Pharmaceuticals is at Unit No 301401 Sai Chambers Chs Ltd Road No 3, Near Santacruz Bus Depot, Mumbai, Maharashtra, India – 400055.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
